Product Images Selegiline Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Selegiline Hydrochloride NDC 16571-659 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
500ct
This appears to be a label of medication called Selegiline Hydrochloride, which comes in a bottle with 500 capsules. The manufacturer could be "Rising" and the product may comply with the United States Pharmacopeia.*
60ct
chemical structure - chemstructure
adverse reactions table - table adverse events v2
This text provides a table that shows the incidence of adverse events in a clinical trial that was placebo-controlled. The trial evaluated the effect of selegiline hydrochloride in a group of 50 patients versus placebo in a group of 49 patients. The table shows the number of patients reporting each adverse event. The adverse events reported in the selegiline hydrochloride group include nausea, dizziness/light-headed/fainting, abdominal pain, confusion, hallucinations, dry mouth, dyskinesias, headache, and vivid dreams. The placebo group reported aches, anxiety/tension, anemia, diarrhea, hair loss, insomnia, leg pain, low back pain, malaise, palpitations, urinary retention, lethargy, and weight loss.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.